Bioanalysis by LCMS

Used for the quantitation of novel small molecule drug candidates in biological samples


You need to login or register to bookmark/favorite this content.

Post author: Andrew Powell. Last update: 13/03/2014 at 12:14 pm by Andrew Powell.





Service overview

Rapid, specific and quantitative analysis of drug candidates in biological samples supports all aspects of ADME lead optimisation at the CDCO. LCMS and LCMS/MS offer the flexibility to develop specific and rapid methods for the analysis of candidate drugs and their metabolites in complex biological matrices.

Additional info


Capacity: We encourage greater utilisation
Operation: Facility provides the service for you
Access: Access by collaboration, Access by fee for service, Access by users external to managing organisation, Access by users internal to managing organisation